US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 77.620
  • -1.190-1.51%
Trading Jan 7 15:36 ET
3.90BMarket Cap32.21P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Haemonetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.015M--
--2025/Q3-- / 352.893M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.015M--
--2025/Q3-- / 352.893M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--

Unlock Free Earnings Estimates

Haemonetics Earnings Reports

  • Haemonetics | 10-Q: Q2 2025 Earnings Report

    Nov 7, 2024 06:13 ET

  • Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2025 Results; Updates Fiscal 2025 Guidance

    Nov 7, 2024 06:09 ET

  • Haemonetics | 10-Q: Q1 2025 Earnings Report

    Aug 8, 2024 06:11 ET

  • Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2025 Results; Reaffirms Fiscal 2025 Guidance

    Aug 8, 2024 06:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data